Yorktown Management & Research Co Inc - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 30 filers reported holding SINOVAC BIOTECH LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Yorktown Management & Research Co Inc ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$4,494
-98.5%
149,786
+100.0%
0.01%
-98.4%
Q2 2023$290,585
-40.1%
74,8930.0%0.31%
-50.4%
Q3 2022$485,0000.0%74,8930.0%0.63%
+0.5%
Q2 2022$485,0000.0%74,8930.0%0.63%
+52.3%
Q1 2022$485,0000.0%74,8930.0%0.41%
+25.3%
Q4 2021$485,0000.0%74,8930.0%0.33%
-10.1%
Q3 2021$485,0000.0%74,8930.0%0.36%
-3.9%
Q2 2021$485,0000.0%74,8930.0%0.38%
-5.7%
Q1 2021$485,0000.0%74,8930.0%0.40%
-7.6%
Q4 2020$485,0000.0%74,8930.0%0.44%
-3.8%
Q3 2020$485,0000.0%74,8930.0%0.45%
+4.4%
Q2 2020$485,0000.0%74,8930.0%0.43%
-11.4%
Q1 2020$485,0000.0%74,8930.0%0.49%
+87.7%
Q4 2019$485,0000.0%74,8930.0%0.26%0.0%
Q3 2019$485,0000.0%74,8930.0%0.26%
+42.6%
Q2 2019$485,0000.0%74,8930.0%0.18%
+16.6%
Q1 2019$485,000
-6.7%
74,8930.0%0.16%
-8.7%
Q4 2018$520,000
-3.2%
74,893
+7.3%
0.17%
+9.6%
Q3 2018$537,000
+11.4%
69,792
+8.0%
0.16%
+12.1%
Q2 2018$482,00064,6450.14%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,500,0006.32%
Vivo Capital, LLC 5,900,000$38,173,0004.21%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.72%
Yorktown Management & Research Co Inc 74,893$485,0000.63%
Skandinaviska Enskilda Banken AB (publ) 40,000$259,0000.00%
Renaissance Technologies 2,375,841$1,537,0000.00%
WELLS FARGO & COMPANY/MN 1,687$11,0000.00%
NORTHERN TRUST CORP 13,787$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$27,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders